Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Epidemiological Situation of Leprosy in the Littoral Region of Cameroon

Lontsi L. S, Kengne F. B, Nechi A. K, et al. European Journal of Medical and Health Research. 2023; 1 (3) : 50-54.
Download PDF
Publication

Genogramas em comunidades afetadas pela hanseníase: explorando aspectos sociais e fatores de risco em Limeira de Mantena - MG

Souza T. D. de M., de Oliveira L. B. P, Velloso-Rodrigues C, et al. Revista Científica FACS. 2023; 23 (2) : 10-24.
Download PDF
Publication

Endemicity in the United States: Leprosy in Louisiana

Gussow Z. Routledge. 1989;
Publication

Novel mutations found in Mycobacterium leprae DNA repair gene nth from central India.

Sharma M, Dwivedi P, Joshi V, et al. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2023;
Publication

Mycobacterium leprae is able to infect adipocytes, inducing lipolysis and modulating the immune response.

Reis S, Gonçalves J, Lima K, et al. Microbes and infection. 2023;
Publication

Risk factors for increasing leprosy treatment dropout cases reported in specific areas in Tangerang District

Kunarisasi S, Puspaningtias J, Segeir F. Bali Medical Journal. 2024; 13 (1) : 216-222.
Download PDF
Publication

Uma visão geral dos aspectos imunológicos nas reações Hansenícas

Júnior D. G. D, Salessi L. N, Maziero L. P, et al. III Seven International Congress of Health. 2023;
Download PDF
Publication

Risk factors of leprosy in daha husada general hospital, Kediri City

Alim S, Umbul Wahyuni C, Indriani D. Universitas Airlangga. Jurnal Berkala Epidemiologi. 2023; 11 (1) : 68-75.
Download PDF
Publication

Spatial analysis reveals failures in leprosy control activities in a hyperendemic city in Brazil

Franca J, Aires C, Nobre M, et al. Lepra. Leprosy Review. 2023; 94 (4) : 276-285.
Download PDF
Publication

Mapping leprosy in Ethiopia: Capture and analysis of district and health facility data to identify and map high leprosy burden districts

Fekadu L, Lambert SM, Kebede T, et al. Lepra. Leprosy Review. 2023; 94 (4) : 264-275.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 9
  • Next page ››
Subscribe to Transmission

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD